Short Squeeze - CMMB
Güncellendi
Idea for Chemomab Therapeutics Ltd.:
- 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk.
- Bottom of Risk Range:
- S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021. fintel.io/doc/sec-chemomab-therapeutics-ltd-ex12-2021-april-30-18747-818
- Cantor Fitzgerald assigned overweight rating on CMMB and raised price target to $45. marketbeat.com/ratings/by-issuer/cantor-fitzgerald-stock-recommendations/
- Good short squeeze material.
- Non Optionable.
Bought the shares $16.69
Expect share dilution $40-$50
GLHF
- DPT
- 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk.
- Bottom of Risk Range:
- S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021. fintel.io/doc/sec-chemomab-therapeutics-ltd-ex12-2021-april-30-18747-818
- Cantor Fitzgerald assigned overweight rating on CMMB and raised price target to $45. marketbeat.com/ratings/by-issuer/cantor-fitzgerald-stock-recommendations/
- Good short squeeze material.
- Non Optionable.
Bought the shares $16.69
Expect share dilution $40-$50
GLHF
- DPT
Emir iptal
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.